Physician profile

Daniel Jovanovich

Cardiovascular Disease · Weirton, WV

NPI 1336105949

$17,769.68

in general payments reported to CMS, 2019-2025

49 companies · $2,433 in 2025

The $2,433 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$6,659.91
Education$99.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Celonova Biosciences, INC. $5,306.26 2020-2021
Medtronic, INC. $1,835.56 2021-2025 Endurant Iis, Hawkone, Abre
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $1,470.85 2019-2025 Lifevest
Shockwave Medical, INC $751.53 2022-2025 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Janssen Pharmaceuticals, INC $709.33 2019-2024 Xarelto
Novo Nordisk INC $683.99 2021-2025 Wegovy, Ozempic, Rybelsus
Boehringer Ingelheim Pharmaceuticals, INC. $589.44 2021-2025 Jardiance
E.R. Squibb & Sons, L.L.C. $556.42 2021-2025 Eliquis, Camzyos
Amgen INC. $463.80 2021-2025 Repatha, Repatha
Astrazeneca Pharmaceuticals LP $446.32 2021-2024 Farxiga, Andexxa, Brilinta
Boston Scientific Corporation $405.28 2021-2025 Watchman Flx, Watchman
Lexicon Pharmaceuticals, INC. $360.74 2023-2024 Inpefa
Inari Medical, INC. $352.84 2022-2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Merck Sharp & Dohme LLC $345.96 2021-2025 Verquvo
Novartis Pharmaceuticals Corporation $339.60 2021-2024
Show all 49 companies
CompanyGeneral paymentsYearsTop products
Pfizer INC. $320.94 2021-2025
Scpharmaceuticals INC. $240.34 2023-2025
Medtronic Vascular, INC. $216.35 2019-2020
Cvrx, INC. $211.71 2022-2024 Barostim Neo System
Abbott Laboratories $205.67 2021-2025 Confirm Rx
Cardiva Medical, INC. $176.13 2019-2021
Actelion Pharmaceuticals US, INC. $172.92 2021-2022
Stryker Corporation $170.05 2025 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Heartflow, INC. $165.85 2025
Irhythm Technologies, INC. $159.61 2023-2024 Zio Xt Patch, Zio Monitor
Biotronik INC. $144.16 2021-2022
Bayer Healthcare Pharmaceuticals INC. $94.40 2022-2023
Amarin Pharma, INC. $92.29 2021-2023
Abbvie INC. $77.05 2023-2024
Sanofi-Aventis U.S. LLC $74.05 2021-2023
Abiomed $71.10 2024-2025 Impella
Mylan Specialty L.P. $65.99 2022-2023 Yupelri
Bard Peripheral Vascular, INC. $56.09 2022
Esperion Therapeutics, INC. $50.65 2021
Glaxosmithkline, LLC. $38.37 2023-2025 Shingrix, Arexvy, Trelegy Ellipta
Bardy Diagnostics, INC. $35.00 2021
Edwards Lifesciences Corporation $31.37 2023
Medicomp INC $30.90 2023 Telepatch Cardiac Monitor
Preventice Services, LLC $29.79 2021
Daiichi Sankyo INC. $28.83 2024 Injectafer
Kowa Pharmaceuticals America, INC. $28.78 2021
Kiniksa Pharmaceuticals, LTD. $28.74 2022-2023 Arcalyst
Kiniksa Pharmaceuticals International, Plc $28.41 2024 Arcalyst
Xeris Pharmaceuticals, INC. $23.39 2024 Keveyis
Azurity Pharmaceuticals, INC. $19.77 2023 Edarbi
Astellas Pharma US INC $17.24 2021
Exact Sciences Corporation $17.06 2024 Cologuard Collection Kit
Vifor Pharma, INC. $14.71 2021
Cook Medical LLC $14.05 2025 Zilver Ptx, Torcon Nb

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Daniel Jovanovich

$17,769.68

in general payments reported 2019-2025

Years
2019-2025
Top company
Celonova Biosciences, INC.
Context
The $2,433 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/105793/daniel-jovanovich

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.